Home » Newsletters » BioWorld Asia

BioWorld Asia

Aug. 8, 2001

View Archived Issues

Pharmacia Spins Off Metabolic Disease Business Into Biovitrum

Ionix Secures #8M In First Round For Ion Channel Work

OSI Acquiring Discovery Arm From British Biotech For $12.4M

Genfit Concludes Two More Deals With Pharma Companies

Compugen, Novartis Collaborate To Accelerate Target Identification

Tibotec-Virco Consolidates Operations In Belgium, U.S.

CellFactors Plans Funding After Getting Bone-Related U.S. Patent

Ichor Changes Name, Continues Focus On Retroviral Diseases

Other News To Note

Pharmexa Plans Spin-Off For Additional Vaccine Applications

Pharming Contemplates Avenues Available To Continue Business

Today's news in brief
BioWorld
BioWorld briefs for Dec. 27, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for December 24, 2024.
Enhanced Cognition: Lewy body dementia phase II pumps stock
BioWorld
Investors will get more details during the International Lewy Body Dementia Conference in Amsterdam late next month, but Wall Street is already buzzing about...
Experimental mRNA gene therapy suppresses preeclampsia in mice
BioWorld MedTech
A gene therapy based on an enhanced lipid nanoparticle (LNP) loaded with vascular endothelial growth factor (VEGF) mRNA could be developed for the treatment of...
Probing bidirectional cancer-autoimmune link can yield new targets
BioWorld Science
Cancer and autoimmunity are “often thought of as being at opposite ends of the immune response,” Ana Anderson told her audience at a joint meeting of the NIH’s...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.